In a patient with uveitis who had been treated with Nd:YAG laser capsulotomy after cataract surgery, several episodes of acute hypotonia occurred which were associated with changes in clinical tests of the eye and of visual function. Immunosuppressive and immunomodulating treatment appeared to reverse the changes in intraocular pressure and normalise the test results. The significance of these observations is discussed. © 1997 Elsevier Science Ltd
INTRODUCTION
After implantation of an intraocular lens, posterior capsular fibrosis may develop with consequent reduction of visual acuity. This is usually treated by Nd:YAG laser capsulotomy. However, some complications of this method have been reported, e.g. an increase of intraocular pressure (Ruderman et al., 1983; Slomovic & Parrish, 1985) . Other complications such as retinal detachment (Powell & Oslon, 1995; Steinert et al., 1991) , uveoscleritis (Herbort, 1994) , or ciliochoroidal effusion (Schaeffer et al., 1989) were reported rarely. In the following report we present clinical and functional data of an uveitis patient, who developed several episodes of severe and visual acuity threatening hypotonia after Nd:YAG laser capsulotomy. According to our knowledge, no similar case has yet been reported.
METHODS
Throughout a follow-up period of 4 years after cataract surgery the patient was examined by two of the authors. Visual acuity was measured with the best refractive correction using the Idemvisus projector. For acuities less than 0.05 hand-held acuity charts have been used with a viewing distance of 1 m. Intraocular pressure was measured with the Goldmann applanation tonometer. Slitlamp examination of the anterior segment and funduscopy was performed using a 90 D lens and a 3 mirror contact lens. Ultrasonographic examinations were also performed by one of the authors using the Cooper Vision Digiscan 2000A with a 10 MHz probe and a resolution of 0.2 mm. Choroidal thickness was measured in B-scans of several sections of the globe, however, only data for the macular region are presented here. Electrooculograms (EOG) and electroretinograms (ERG) were recorded and analysed according to ISCEV recommendations (Marmor et al., 1989; Marmor & Zrenner, 1993) using the MK 15 system of Amplaid, Milan, Italy.
CASE REPORT
A 40-year-old Caucasian woman had recurrent panuveitis for which she had been treated in our department since 1989. Serological tests disclosed a lues satis curata. The primary syphilitic infection was unknown. Specific dermatological changes were not seen. Antibiotics considerably improved her condition and during the follow-up, serology and also slit lamp examination showed no signs of active disease. However, 3 years later she complained of a progressive reduction in visual acuity owing to cataract formation in her right eye. We decided to perform cataract extraction by phacoemulsification and implantation of a posterior chamber lens. Surgery was performed without any complications. Visual acuity increased from 0.3 preoperatively to 0.5 postoperatively 2 days after surgery. No better visual acuity was achieved owing to a primary fibrosis of the posterior capsule. No signs of inflammation were found after surgery. On day 54 after cataract surgery visual acuity was found to be 1/35, owing to a dense fibrosis of the posterior capsule. Intraocular pressure was 14 mm Hg. We performed a posterior capsulotomy using the Nd:YAG laser (Zeiss, 8 shots, 2.2 mJ energy). Visual acuity increased to 0.7 immediately. One week later she complained of reduced visual acuity in this eye. Visual acuity was found to be 0.2 and intraocular pressure was 2 mm Hg. No signs of intraocular inflammation could be found. In addition, a retinal or ciliary body detachment could be excluded by ophthalmoscopy and by ultrasonography. A moderate global choroidal swelling was described. A maculopathy owing to hypotonia was not seen. We started treatment with 100 mg Fluocortenol (Ultralan oral) daily for 7 days. Visual acuity and intraocular pressure remained reduced during this medication. Next, we supplemented the immunosuppressive treatment with an immunomodulating therapy with 10 g of 7s Immunoglobulins (Sandoglobulin) i.v. twice daily for 10 days. Simultaneously we reduced the steroid dosage in steps of 25 mg each week, down to 10 mg Fluocortenol daily between days 35 and 40 after the YAG capsulotomy. Under this treatment visual acuity and intraocular pressure increased and the choroidal swelling resolved. After withdrawal of the systemic steroid medication another drop in visual acuity (from 0.7 to 0.3) and intraocular pressure (from 9 to 3 mm Hg) was observed. Again, we treated her successfully with 50 mg Fluocortenol daily and 10 g 7s Immunoglobulins i.v. twice daily for 11 days and reduced the steroids in steps of 10 mg every second day. However, 3 weeks later the patient again presented a very low lOP (3 mm Hg) with a severe reduction of visual acuity (from 0.5, 9 weeks after laser capsulotomy to 0.05, 12 weeks after the laser treatment). Again, the patient presented no signs of hypotonous maculopathy, inflammation, retinal or ciliary body detachment. We treated her with 7s Immunoglobulins 10mg i.v. twice daily and Fluocortenol 100mg orally once daily. The hypotonia resolved. Visual acuity increased and choroidal thickness was found to be normal at the end of the treatment. Intraocular pressure and visual acuity has remained constant for 4 years now with a visual acuity of 0.6 d-0.1 on the right eye and an lOP of 12 ± 3 mm Hg.
RESULTS AND DISCUSSION
In the above-described case several episodes of hypotonia are described associated with a loss of visual acuity. A combined treatment with corticosteroids and 7s Immunoglobulins was successful in each of these episodes. Figure 1 describes the course of intraocular pressure and visual acuity during the first and second hypotonous episode. The data showed the time lag between pressure increase and visual acuity increase under combined treatment (arrows). It should be noted that a simple oral steroid treatment was not successful. The lOP increase was always correlated with a reduction of choroidal thickness. The corresponding data are given in Fig. 2 . During the episodes of hypotonia the overall refractive error changed significantly to more hyperopic values, i.e. with an IOD> 10mm Hg the spherical equivalent was +1.085 + 0.997 D (mean ___ SD); with an IOP < 10 the spherical equivalent was +3.171 + 0.978 D (mean + SD). Despite a drop of lOP between days 25 and 35 after Nd:YAG capsulotomy choroidal thickness and visual acuity remained constant. In contrast, the drop of IOP between days 42 and 47, when the patient was without treatment, caused a swelling of the choroid and a reduction of visual acuity. With repeated applications of 7s Immunoglobulins and steroids during the last episode of pressure loss, 96 days after the YAG capsulotomy an increase of visual acuity could be achieved and further episodes of hypotonia could be prevented. Intraocular FIGURE 5. Scattergram of EOG dark-trough and EOG light-rise values. Two data groups can be identified: dark trough >20 pV means light-rise approx. 200% ("normal light-rise"); dark-trough <20 #V means light-rise >400% ("supemonnal light-rise").
rise and/or peak-time and dark-trough, respectively. The ERG was always normal without any significant variation over the 4-year follow-up period (Fig. 6 ).
The mechanism of hypotonia in this case remained unclear; neither a retinal detachment, nor a detachment of the ciliary body could be found, which might have been Furthermore, no signs of intraocular inflammation were observed. The effect of a combination of immunomodulating and immunosuppressive treatment suggest an uveitis-linked mechanism affecting aqueous humor production or outflow, or both. Such a mechanism is indeed supported by the refractive changes being observed. Unfortunately, anterior chamber depth and flow were not measured. The mechanism could be triggered either by mechanical stress after Nd:YAG laser capsulotomy or by mediators of inflammation activated by the laser treatment. The involvement of the latter seemed to be likely, because it was shown in this case, that a combination of steroids and 7s Immunoglobulins was useful in the treatment of this rarely observed sideeffect of YAG capsulotomy in cases of uveitis. In diabetic patients with neovascular glaucoma after laser disruption of the posterior capsula, it was suggested that the breakdown of the barrier between the anterior and the posterior compartment enhances the diffusion of vasoproliferative mediators to the anterior segment (Weinreb et al., 1986) . One may hypothesize the involvement of inflammatory mediators with a similar mechanism in the case presented here.
The normal ERG (Fig. 6 ) throughout the 4 years of follow-up indicates a normal stimulus-response function of photoreceptors and higher-order retinal neurons on a short-term scale, despite the sonographic evidence of choroidal swelling. It could be speculated that a longer period of hypotonia would have an effect on the ERG, but under successful treatment, ERG changes could be prevented.
The EOG was altered with changes of lOP and choroidal thickness. However, only the dark-trough and not the light-rise correlated with choroidal thickness. The correlation between EOG dark-trough and lOP was not as good as with choroidal thickness. This could be explained by the delay between IOP rise and reduction of choroidal swelling. As a conclusion one may assume that RPE dysfunction due to choroidal swelling is the reason for visual impairment. (The refractive changes were always compensated.) From a large number of in vitro studies and also from clinical observations in cases of diffuse RPE damage it is now well established that the origin of the EOG amplitudes is at the level of the RPE (e.g. Griff & Steinberg, 1982; Linsenmeier & Steinberg, 1987) . Thus, EOG pathology is usually interpreted as RPE pathology. However, photoreceptor processes and
